Ulrik Ralfkiær

Screening for copy‐number alterations and loss of heterozygosity in chronic lymphocytic leukemia—A comparative study of four differently designed, high resolution microarray platforms

Rebeqa Gunnarsson, Johan Staaf, Mattias Jansson et al. · Genes Chromosomes and Cancer · 2008 · 114 citations

Life Sciences, Genetics, Oncology +17

Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of <i>FGFR3</i> mutations and hypermethylation events

Reza Serizawa, Ulrik Ralfkiær, Kenneth Steven et al. · International Journal of Cancer · 2010 · 98 citations

Medicine, Genetics, Oncology +17

Equitoxic Doses of 5-Azacytidine and 5-Aza-2′Deoxycytidine Induce Diverse Immediate and Overlapping Heritable Changes in the Transcriptome

Xiangning Qiu, Christoffer Hother, Ulrik Ralfkiær et al. · PLoS ONE · 2010 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator

Anna Juncker‐Jensen, Anne E. Lykkesfeldt, Jesper Worm et al. · Growth Hormone & IGF Research · 2006 · 42 citations

Medicine, Cancer Biology, Oncology +7

MicroRNA Profiling in Ocular Adnexal Lymphoma: A Role for MYC and NFKB1 Mediated Dysregulation of MicroRNA Expression in Aggressive Disease

Christoffer Hother, P Rasmussen, Tejal Joshi et al. · Investigative Ophthalmology & Visual Science · 2013 · 33 citations

Medicine, Molecular Biology, Oncology +15